Analyst Activity – Cowen and Company Reiterates Outperform on GenMark Diagnostics (NASDAQ:GNMK)

ME Staff
-
0

Analyst Ratings For GenMark Diagnostics (NASDAQ:GNMK)

Today, Cowen and Company reiterated its Outperform rating on GenMark Diagnostics (NASDAQ:GNMK) with a price target of $17.00.

There are 4 buy ratings on the stock.

The current consensus rating on GenMark Diagnostics (NASDAQ:GNMK) is Buy (Score: 3.00) with a consensus target price of $17.00 per share, a potential 58.80% upside.

Some recent analyst ratings include

  • 8/2/2017-Cowen and Company Reiterated Rating of Outperform.
  • 6/12/2017-Canaccord Genuity Reiterated Rating of Buy.
  • 5/17/2017-BTIG Research Reiterated Rating of Buy.

Recent Insider Trading Activity For GenMark Diagnostics (NASDAQ:GNMK)
GenMark Diagnostics (NASDAQ:GNMK) has insider ownership of 7.50% and institutional ownership of 92.58%.

  • On 6/2/2017 Michael Gleeson, SVP, sold 357 with an average share price of $12.89 per share and the total transaction amounting to $4,601.73. View SEC Filing
  • On 5/19/2017 Hany Massarany, Insider, sold 8,239 with an average share price of $12.89 per share and the total transaction amounting to $106,200.71. View SEC Filing
  • On 5/19/2017 Michael Gleeson, SVP, sold 1,916 with an average share price of $12.89 per share and the total transaction amounting to $24,697.24. View SEC Filing
  • On 5/19/2017 Scott Mendel, CFO, sold 2,135 with an average share price of $12.89 per share and the total transaction amounting to $27,520.15. View SEC Filing
  • On 5/16/2017 Scott Mendel, CFO, sold 1,268 with an average share price of $13.43 per share and the total transaction amounting to $17,029.24. View SEC Filing
  • On 5/2/2017 Eric Stier, SVP, sold 362 with an average share price of $13.34 per share and the total transaction amounting to $4,829.08. View SEC Filing
  • On 5/2/2017 Hany Massarany, Insider, sold 1,571 with an average share price of $13.34 per share and the total transaction amounting to $20,957.14. View SEC Filing

Recent Trading Activity for GenMark Diagnostics (NASDAQ:GNMK)
Shares of GenMark Diagnostics closed the previous trading session at 10.52 down -0.18 -1.73% with 3,119,052 shares trading hands.